Ponvory Now Available in Scotland at Low or No Cost Through NHS

Ponvory Now Available in Scotland at Low or No Cost Through NHS

311816

Ponvory Now Available in Scotland at Low or No Cost Through NHS

The Scottish Medicines Consortium (SMC) has recommended that Ponvory (ponesimod) be offered through the National Health Service (NHS) Scotland to people with active, relapsing forms of multiple sclerosis (MS). The decision means that the oral therapy will be available at low or no cost to patients with clinically isolated syndrome (CIS), relapsing-remitting MS (RRMS), and active secondary progressive MS (SPMS). “It’s very welcome that ponesimod has been approved for use on the NHS in Scotland,” Morna Simpkins, Scotland director at the U.K.’s…

You must be logged in to read/download the full post.